1 |
0,5 mg prevenar i.m. |
- |
- |
- |
- |
051 [1] 51 💬 |
2 |
0,5 mg seasonal influenza vaccine i.m. |
- |
- |
- |
- |
051 [1] 51 💬 |
3 |
0.9% sodium chloride |
Chloride ion |
[1] D02056 D02056 💬 |
- |
- |
006 [4] 6 , 14, 51, 53 💬 |
4 |
1-(6-benzothiazolylsulfonyl)-5-chloro-1h-indole-2-butanoic acid |
Butyric Acid |
[1] D05866 D05866 💬 |
- |
- |
051 [1] 51 💬 |
5 |
1-22460 |
- |
- |
- |
- |
051 [1] 51 💬 |
6 |
10% nitroglycerine in propylene glycol, usp |
Nitroglycerin |
[2] D00078 D00078, D00515 D00515 💬 |
- |
- |
051 [1] 51 💬 |
7 |
3-[4-(1h-imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)thiophene-2-[(n-butyloxylcarbamate)-sulphonamide] sodium salt |
- |
- |
- |
- |
051 [2] 51, 85 💬 |
8 |
Abatacept |
Abatacept |
[1] D03203 D03203 💬 |
CD80 [2] CD80, CD86 💬 |
Allograft rejection [12] Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis |
011 [26] 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬 |
9 |
Abituzumab |
Abituzumab |
- |
- |
- |
051 [1] 51 💬 |
10 |
Abituzumab 1500 mg |
Abituzumab |
- |
- |
- |
051 [1] 51 💬 |
11 |
Abituzumab 500 mg |
Abituzumab |
- |
- |
- |
051 [1] 51 💬 |
12 |
Abr-215757 |
- |
- |
- |
- |
049 [2] 49, 51 💬 |
13 |
Acetaminophen |
Acetaminophen |
[1] D00217 D00217 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
011 [14] 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬 |
14 |
Acetate |
Acetate |
- |
- |
- |
001 [43] 1 , 2 , 6 , 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 💬 |
15 |
Acetylcysteine |
Acetylcysteine |
[1] D00221 D00221 💬 |
- |
- |
006 [16] 6 , 13, 19, 20, 34, 49, 51, 58, 85, 94, 111, 164, 193, 233, 298, 299 💬 |
16 |
Acetylsalicylic acid |
Acetylsalicylic acid |
[1] D00109 D00109 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 [4] 13, 46, 51, 210 💬 |
17 |
Achim as solute (10^9 intestinal microbes/ml) |
- |
- |
- |
- |
051 [1] 51 💬 |
18 |
Acotiamide |
Acotiamide |
- |
- |
- |
051 [1] 51 💬 |
19 |
Act-064992 |
- |
- |
- |
- |
051 [5] 51, 85, 86, 88, 210 💬 |
20 |
Act-293987 |
- |
- |
- |
- |
051 [3] 51, 86, 88 💬 |
21 |
Adempas |
- |
- |
- |
- |
051 [5] 51, 86, 88, 225, 299 💬 |
22 |
Adempas - 1 mg - compressa rivestita con film - uso orale - blister (pp/alu) - 42 compresse |
- |
- |
- |
- |
051 [2] 51, 86 💬 |
23 |
Adempas - 1,5 mg - compressa rivestita con film - uso orale - blister (pp/alu) - 42 compresse |
- |
- |
- |
- |
051 [2] 51, 86 💬 |
24 |
Adempas - 2 mg - compressa rivestita con film - uso orale - blister (pp/alu) - 42 compresse |
- |
- |
- |
- |
051 [2] 51, 86 💬 |
25 |
Adempas - 2,5 mg - compressa rivestita con film - uso orale - blister (pp/alu) - 42 compresse |
- |
- |
- |
- |
051 [2] 51, 86 💬 |
26 |
Administration of rituximab and methylprednisolone |
Methylprednisolone |
[7] D00407 D00407, D00751 D00751, D00979 D00979, D02994 D02994, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
MS4A1 [2] MS4A1, NR3C1 💬 |
Hematopoietic cell lineage [2] Hematopoietic cell lineage, Neuroactive ligand-receptor interaction |
051 [1] 51 💬 |
27 |
Adsvf application in the right hand |
- |
- |
- |
- |
051 [1] 51 💬 |
28 |
Aimspro |
- |
- |
- |
- |
013 [2] 13, 51 💬 |
29 |
Air |
- |
- |
- |
- |
003 [7] 3 , 51, 58, 85, 97, 193, 299 💬 |
30 |
Ajulemic acid |
Ajulemic acid |
[1] D11312 D11312 💬 |
CNR2 [1] CNR2 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
050 [3] 50, 51, 299 💬 |
31 |
Al |
- |
- |
- |
- |
005 [9] 5 , 6 , 7 , 28, 51, 67, 86, 114, 127 💬 |
32 |
Albumin |
- |
- |
- |
- |
002 [3] 2 , 20, 51 💬 |
33 |
Alemtuzumab |
Alemtuzumab |
[1] D02802 D02802 💬 |
- |
- |
013 [16] 13, 15, 19, 20, 43, 44, 46, 51, 60, 63, 65, 85, 96, 164, 283, 284 💬 |
34 |
Alginic acid |
Alginic acid |
[1] D02324 D02324 💬 |
- |
- |
051 [1] 51 💬 |
35 |
Allogeneic mesenchymal stem cells (allomsc) |
- |
- |
- |
- |
051 [2] 51, 53 💬 |
36 |
Alpha-2c ar antagonist |
- |
- |
- |
- |
051 [1] 51 💬 |
37 |
Alprostadil |
Alprostadil |
[2] D00180 D00180, D02705 D02705 💬 |
PTGER1 [1] PTGER1 💬 |
Calcium signaling pathway [4] Calcium signaling pathway, Human cytomegalovirus infection, Neuroactive ligand-receptor interaction, Pathways in cancer |
051 [2] 51, 70 💬 |
38 |
Am-01 |
- |
- |
- |
- |
051 [1] 51 💬 |
39 |
Ambrisentan |
Ambrisentan |
[1] D07077 D07077 💬 |
EDNRA [1] EDNRA 💬 |
Calcium signaling pathway [7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 [7] 51, 84, 85, 86, 88, 210, 211 💬 |
40 |
Amlodipine |
Amlodipine |
[3] D00615 D00615, D02914 D02914, D07450 D07450 💬 |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
Adrenergic signaling in cardiomyocytes [36] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 [3] 51, 67, 298 💬 |
41 |
Amlodipine gel |
Amlodipine |
[3] D00615 D00615, D02914 D02914, D07450 D07450 💬 |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
Adrenergic signaling in cardiomyocytes [36] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 [1] 51 💬 |
42 |
Anaerobically cultivated human intestinal microbiota |
- |
- |
- |
- |
051 [1] 51 💬 |
43 |
Anaerobically cultivated medium |
- |
- |
- |
- |
051 [1] 51 💬 |
44 |
Anti-ct51 antigen mab |
- |
- |
- |
- |
051 [1] 51 💬 |
45 |
Anti-human t-lymphocyte immunoglobulin from rabbits |
- |
- |
- |
- |
051 [1] 51 💬 |
46 |
Anti-integrin alphav mab |
- |
- |
- |
- |
051 [1] 51 💬 |
47 |
Anti-pandemic h1n1 influenza vaccine |
- |
- |
- |
- |
046 [5] 46, 49, 50, 51, 53 💬 |
48 |
Anti-thymocyte globulin |
- |
- |
- |
- |
011 [18] 11, 13, 14, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 164, 283, 284, 285 💬 |
49 |
Anti-thymocyte globulin, rabbit |
Rabbit |
- |
- |
- |
051 [1] 51 💬 |
50 |
Asasantin retard |
- |
- |
- |
- |
051 [1] 51 💬 |
51 |
Asasantin retard ® |
- |
- |
- |
- |
051 [1] 51 💬 |
52 |
Asc |
- |
- |
- |
- |
036 [4] 36, 51, 96, 97 💬 |
53 |
Aspirin |
Acetylsalicylic acid |
[1] D00109 D00109 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 [11] 13, 22, 34, 46, 49, 51, 86, 113, 158, 210, 231 💬 |
54 |
Atorvastatin |
Atorvastatin |
[3] D00258 D00258, D00887 D00887, D07474 D07474 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 [17] 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 💬 |
55 |
Auc of mpa measure |
- |
- |
- |
- |
051 [1] 51 💬 |
56 |
Autologous asc |
- |
- |
- |
- |
051 [1] 51 💬 |
57 |
Autologous stem cells |
- |
- |
- |
- |
013 [2] 13, 51 💬 |
58 |
Autologous stemcell transplantation with cd (cluster of differentiation) 34 selected stem cells |
- |
- |
- |
- |
051 [1] 51 💬 |
59 |
Avid200 |
- |
- |
- |
- |
051 [1] 51 💬 |
60 |
Aviptadil |
Aviptadil |
- |
- |
- |
049 [4] 49, 51, 85, 86 💬 |
61 |
Bay63-2521 |
- |
- |
- |
- |
051 [3] 51, 86, 299 💬 |
62 |
Beam |
Tricyclazole |
- |
- |
- |
006 [2] 6 , 51 💬 |
63 |
Belimumab |
Belimumab |
[1] D03068 D03068 💬 |
TNFSF13B [1] TNFSF13B 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
011 [10] 11, 43, 44, 46, 49, 51, 53, 66, 222, 300 💬 |
64 |
Belumosudil (kd025) |
- |
- |
- |
- |
051 [1] 51 💬 |
65 |
Bermekimab |
Bermekimab |
[1] D11253 D11253 💬 |
IL1A [1] IL1A 💬 |
AGE-RAGE signaling pathway in diabetic complications [21] AGE-RAGE signaling pathway in diabetic complications, Alzheimer disease, Cellular senescence, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Inflammatory bowel disease, Influenza A, Leishmaniasis, MAPK signaling pathway, Measles, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Tuberculosis, Type I diabetes mellitus |
051 [1] 51 💬 |
66 |
Bh4 |
- |
- |
- |
- |
051 [5] 51, 86, 124, 240, 299 💬 |
67 |
Bibf 1120 |
- |
- |
- |
- |
051 [2] 51, 85 💬 |
68 |
Biopsy |
- |
- |
- |
- |
019 [2] 19, 51 💬 |
69 |
Blood coagulation factor xiii |
Factor XIII (human) |
- |
- |
- |
051 [1] 51 💬 |
70 |
Blood sample |
- |
- |
- |
- |
008 [13] 8 , 13, 46, 49, 51, 53, 61, 66, 84, 97, 274, 288, 299 💬 |
71 |
Blood samples |
- |
- |
- |
- |
013 [8] 13, 41, 46, 51, 61, 97, 227, 271 💬 |
72 |
Blood sampling |
- |
- |
- |
- |
013 [5] 13, 17, 19, 51, 96 💬 |
73 |
Bms-986020 |
BMS-986020 |
- |
- |
- |
051 [2] 51, 85 💬 |
74 |
Bortezomib |
Bortezomib |
[1] D03150 D03150 💬 |
PSMB5 [1] PSMB5 💬 |
Alzheimer disease [8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia |
011 [15] 11, 13, 26, 28, 46, 49, 51, 61, 63, 66, 228, 256, 283, 288, 331 💬 |
75 |
Bosentan |
Bosentan |
[2] D01227 D01227, D07538 D07538 💬 |
EDNRA [2] EDNRA, EDNRB 💬 |
Calcium signaling pathway [9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 [11] 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬 |
76 |
Bosentan (tracleer) |
Bosentan |
[2] D01227 D01227, D07538 D07538 💬 |
EDNRA [2] EDNRA, EDNRB 💬 |
Calcium signaling pathway [9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 [1] 51 💬 |
77 |
Bosentan 125 mg |
Bosentan |
[2] D01227 D01227, D07538 D07538 💬 |
EDNRA [2] EDNRA, EDNRB 💬 |
Calcium signaling pathway [9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 [1] 51 💬 |
78 |
Bosentan 62.5 mg |
Bosentan |
[2] D01227 D01227, D07538 D07538 💬 |
EDNRA [2] EDNRA, EDNRB 💬 |
Calcium signaling pathway [9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 [1] 51 💬 |
79 |
Bosentan group |
Bosentan |
[2] D01227 D01227, D07538 D07538 💬 |
EDNRA [2] EDNRA, EDNRB 💬 |
Calcium signaling pathway [9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 [1] 51 💬 |
80 |
Bosentan monohydrate |
Bosentan |
[2] D01227 D01227, D07538 D07538 💬 |
EDNRA [2] EDNRA, EDNRB 💬 |
Calcium signaling pathway [9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 [4] 51, 84, 86, 88 💬 |
81 |
Botox |
- |
- |
- |
- |
002 [6] 2 , 6 , 13, 51, 149, 226 💬 |
82 |
Botox® solution |
- |
- |
- |
- |
051 [1] 51 💬 |
83 |
Botulinum toxin a |
Botulinum toxin type A |
[1] D00783 D00783 💬 |
SNAP25 [1] SNAP25 💬 |
Insulin secretion [2] Insulin secretion, Synaptic vesicle cycle |
013 [4] 13, 51, 149, 226 💬 |
84 |
Botulinum toxin type b |
Botulinum Toxin Type B |
[1] D02735 D02735 💬 |
SNAP25 [1] SNAP25 💬 |
Insulin secretion [2] Insulin secretion, Synaptic vesicle cycle |
002 [3] 2 , 6 , 51 💬 |
85 |
Botulinum toxin type b (2500 units / vial) |
Botulinum Toxin Type B |
[1] D02735 D02735 💬 |
SNAP25 [1] SNAP25 💬 |
Insulin secretion [2] Insulin secretion, Synaptic vesicle cycle |
051 [1] 51 💬 |
86 |
Botulinum toxin(botox) |
- |
- |
- |
- |
051 [1] 51 💬 |
87 |
Bovine type i collagen |
Bovine type I collagen |
- |
- |
- |
051 [1] 51 💬 |
88 |
Brentuximab |
Brentuximab vedotin |
[1] D09587 D09587 💬 |
TNFRSF8 [10] TNFRSF8, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 |
Alzheimer disease [11] Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection |
049 [2] 49, 51 💬 |
89 |
Brentuximab vedotin |
Brentuximab vedotin |
[1] D09587 D09587 💬 |
TNFRSF8 [10] TNFRSF8, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 |
Alzheimer disease [11] Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection |
049 [2] 49, 51 💬 |
90 |
Brodalumab |
Brodalumab |
[1] D10061 D10061 💬 |
IL17RA [1] IL17RA 💬 |
Cytokine-cytokine receptor interaction [2] Cytokine-cytokine receptor interaction, IL-17 signaling pathway |
037 [2] 37, 51 💬 |
91 |
Bupivacaine |
Bupivacaine |
[2] D01450 D01450, D07552 D07552 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
046 [8] 46, 51, 53, 70, 96, 168, 226, 298 💬 |
92 |
Buspirone |
Buspirone |
[2] D00702 D00702, D07593 D07593 💬 |
DRD2 [2] DRD2, HTR1A 💬 |
Alcoholism [10] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway |
006 [2] 6 , 51 💬 |
93 |
Busulfan |
Busulfan |
[1] D00248 D00248 💬 |
- |
- |
019 [13] 19, 20, 28, 36, 49, 51, 60, 65, 164, 274, 284, 285, 326 💬 |
94 |
Butanoic acid |
Butyric Acid |
[1] D05866 D05866 💬 |
- |
- |
034 [3] 34, 51, 97 💬 |
95 |
C-82 topical gel, 1% |
- |
- |
- |
- |
051 [1] 51 💬 |
96 |
C21 |
- |
- |
- |
- |
051 [2] 51, 85 💬 |
97 |
C225 |
- |
- |
- |
- |
051 [2] 51, 86 💬 |
98 |
Calcipotriene |
Calcipotriol |
[1] D01125 D01125 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
051 [1] 51 💬 |
99 |
Calcium |
Calcium |
- |
- |
- |
006 [27] 6 , 13, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 186, 214, 215, 222, 224, 235, 265, 274, 298, 299 💬 |
100 |
Calcium channel blockers |
Calcium |
- |
- |
- |
051 [1] 51 💬 |
101 |
Cam2043 |
- |
- |
- |
- |
051 [1] 51 💬 |
102 |
Campath |
- |
- |
- |
- |
019 [12] 19, 20, 49, 51, 60, 62, 65, 164, 234, 283, 285, 326 💬 |
103 |
Capillarema |
- |
- |
- |
- |
051 [1] 51 💬 |
104 |
Carbon |
Activated charcoal |
[1] D03251 D03251 💬 |
- |
- |
006 [9] 6 , 46, 50, 51, 85, 86, 96, 97, 298 💬 |
105 |
Carbon dioxide |
Activated charcoal |
[2] D00004 D00004, D03251 D03251 💬 |
- |
- |
050 [3] 50, 51, 97 💬 |
106 |
Cc |
- |
- |
- |
- |
013 [13] 13, 28, 46, 49, 51, 56, 84, 85, 96, 97, 162, 202, 271 💬 |
107 |
Cc-4047 |
- |
- |
- |
- |
028 [2] 28, 51 💬 |
108 |
Cd |
- |
- |
- |
- |
006 [6] 6 , 46, 51, 96, 97, 265 💬 |
109 |
Cd34 selected autologous hematopoietic cells |
- |
- |
- |
- |
051 [1] 51 💬 |
110 |
Cd34+sc |
- |
- |
- |
- |
051 [1] 51 💬 |
111 |
Cetuximab |
Cetuximab |
[1] D03455 D03455 💬 |
EGFR [1] EGFR 💬 |
Adherens junction [46] Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease - COVID-19, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis |
034 [5] 34, 51, 86, 89, 331 💬 |
112 |
Chloride |
Chloride ion |
- |
- |
- |
006 [25] 6 , 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 78, 96, 97, 127, 168, 171, 193, 227, 228, 271, 288, 296, 297, 299 💬 |
113 |
Cialis |
- |
- |
- |
- |
051 [2] 51, 86 💬 |
114 |
Cilostazol |
Cilostazol |
[1] D01896 D01896 💬 |
PDE3A [3] PDE3A, PDE3B, TBXA2R 💬 |
Apelin signaling pathway [14] Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Platelet activation, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 [2] 51, 70 💬 |
115 |
Clobetasol |
Clobetasol |
[1] D07715 D07715 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
039 [4] 39, 46, 51, 162 💬 |
116 |
Cuprimine (penicillamine) |
Penicillamine |
[1] D00496 D00496 💬 |
- |
- |
051 [1] 51 💬 |
117 |
Currently available therapy in the community |
- |
- |
- |
- |
051 [1] 51 💬 |
118 |
Cutaneous iontophoresis of treprostinil |
Treprostinil |
[1] D06213 D06213 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
051 [1] 51 💬 |
119 |
Cyclophosphamide |
Cyclophosphamide |
[2] D00287 D00287, D07760 D07760 💬 |
- |
- |
011 [44] 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬 |
120 |
Cyclophosphamide injection 1g |
Cyclophosphamide |
[2] D00287 D00287, D07760 D07760 💬 |
- |
- |
050 [3] 50, 51, 52 💬 |
121 |
Dabigatran |
Dabigatran |
[1] D09707 D09707 💬 |
F2 [1] F2 💬 |
Complement and coagulation cascades [8] Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton |
051 [4] 51, 85, 91, 124 💬 |
122 |
Dabigatran etexilate |
Dabigatran |
[2] D07144 D07144, D09707 D09707 💬 |
F2 [1] F2 💬 |
Complement and coagulation cascades [8] Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton |
051 [1] 51 💬 |
123 |
Dasatinib |
Dasatinib |
[2] D03658 D03658, D06414 D06414 💬 |
ABL1 [8] ABL1, EPHA2, FYN, KIT, LCK, PDGFRB, SRC, YES1 💬 |
Acute myeloid leukemia [74] Acute myeloid leukemia, Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, Glioma, GnRH signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Mitophagy - animal, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Primary immunodeficiency, Prion disease, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Sphingolipid signaling pathway, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection |
051 [2] 51, 85 💬 |
124 |
Depot leuprolide acetate 3.75 mg |
Acetate |
[2] D00989 D00989, D08113 D08113 💬 |
GNRHR [1] GNRHR 💬 |
GnRH signaling pathway [2] GnRH signaling pathway, Neuroactive ligand-receptor interaction |
051 [1] 51 💬 |
125 |
Dersimelagon |
- |
- |
- |
- |
051 [2] 51, 254 💬 |
126 |
Device: air filled balloon catheter |
- |
- |
- |
- |
051 [1] 51 💬 |
127 |
Device: fractional carbon dioxide laser |
Activated charcoal |
[2] D00004 D00004, D03251 D03251 💬 |
- |
- |
051 [1] 51 💬 |
128 |
Device: manual toothbrush |
- |
- |
- |
- |
051 [1] 51 💬 |
129 |
Device: manual toothbrush and water flosser (philips sonicare airfloss) |
Water |
[1] D00001 D00001 💬 |
- |
- |
051 [1] 51 💬 |
130 |
Device: measurment with aspirational medical device |
- |
- |
- |
- |
051 [1] 51 💬 |
131 |
Device: measurment with cutometer mpa 580 |
- |
- |
- |
- |
051 [1] 51 💬 |
132 |
Device: serial night time position splint |
- |
- |
- |
- |
051 [1] 51 💬 |
133 |
Device: solid state catheter |
- |
- |
- |
- |
051 [1] 51 💬 |
134 |
Device: sonic toothbrush |
- |
- |
- |
- |
051 [1] 51 💬 |
135 |
Device: sonic toothbrush (philips sonicare) and water flosser (philips sonicare airfloss) |
Water |
[1] D00001 D00001 💬 |
- |
- |
051 [1] 51 💬 |
136 |
Device: the ozone generator device (human pro medic, german) |
Ozone |
- |
- |
- |
051 [1] 51 💬 |
137 |
Device: ultraviolet a1 phototherapy (uva1) |
- |
- |
- |
- |
051 [1] 51 💬 |
138 |
Di-17e6 |
- |
- |
- |
- |
051 [1] 51 💬 |
139 |
Diagnostic test: cmri |
- |
- |
- |
- |
051 [2] 51, 86 💬 |
140 |
Diagnostic test: imaging |
- |
- |
- |
- |
051 [1] 51 💬 |
141 |
Diagnostic test: p-mpa concentration |
- |
- |
- |
- |
051 [1] 51 💬 |
142 |
Diagnostic test: pulmonary function test |
- |
- |
- |
- |
051 [1] 51 💬 |
143 |
Digna p144 cream |
- |
- |
- |
- |
051 [1] 51 💬 |
144 |
Diltiazem |
Diltiazem |
[3] D00616 D00616, D03830 D03830, D07845 D07845 💬 |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
Adrenergic signaling in cardiomyocytes [36] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 [3] 51, 58, 86 💬 |
145 |
Diltiazem gel 2% |
Diltiazem |
[3] D00616 D00616, D03830 D03830, D07845 D07845 💬 |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
Adrenergic signaling in cardiomyocytes [36] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 [1] 51 💬 |
146 |
Dimethyl fumarate |
Dimethyl fumarate |
[1] D03846 D03846 💬 |
KEAP1 [1] KEAP1 💬 |
Fluid shear stress and atherosclerosis [4] Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquitin mediated proteolysis |
013 [4] 13, 51, 86, 296 💬 |
147 |
Dimethyl fumarate (dmf) |
Dimethyl fumarate |
[1] D03846 D03846 💬 |
KEAP1 [1] KEAP1 💬 |
Fluid shear stress and atherosclerosis [4] Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquitin mediated proteolysis |
013 [3] 13, 51, 86 💬 |
148 |
Diphenhydramine |
Diphenhydramine |
[6] D00300 D00300, D00669 D00669, D02419 D02419, D03285 D03285, D03360 D03360, D03854 D03854 💬 |
HRH1 [1] HRH1 💬 |
Calcium signaling pathway [3] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
011 [8] 11, 49, 51, 70, 86, 96, 222, 256 💬 |
149 |
Dipyridamole |
Dipyridamole |
[1] D00302 D00302 💬 |
PDE4A [2] PDE4A, PDE5A 💬 |
Metabolic pathways [6] Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway |
046 [5] 46, 49, 51, 66, 224 💬 |
150 |
Divalproex sodium |
- |
- |
- |
- |
051 [1] 51 💬 |
151 |
Domperidone |
Domperidone |
[2] D01745 D01745, D07868 D07868 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [5] 6 , 13, 17, 51, 230 💬 |
152 |
Double-blind rituximab |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
051 [1] 51 💬 |
153 |
Drug treatment |
- |
- |
- |
- |
046 [4] 46, 51, 74, 271 💬 |
154 |
Dupilumab |
Dupilumab |
[1] D10354 D10354 💬 |
IL4R [1] IL4R 💬 |
Cytokine-cytokine receptor interaction [8] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation |
051 [4] 51, 98, 160, 162 💬 |
155 |
Dupilumab 300mg solution for injection |
Dupilumab |
[1] D10354 D10354 💬 |
IL4R [1] IL4R 💬 |
Cytokine-cytokine receptor interaction [8] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation |
051 [1] 51 💬 |
156 |
Edta |
Edetic acid |
[8] D00052 D00052, D00571 D00571, D01802 D01802, D03943 D03943, D03944 D03944, D03945 D03945, D03946 D03946, D03947 D03947 💬 |
- |
- |
051 [2] 51, 60 💬 |
157 |
Ema/chmp/212874/2015 |
- |
- |
- |
- |
051 [1] 51 💬 |
158 |
Emd 525797 |
- |
- |
- |
- |
051 [1] 51 💬 |
159 |
Endoprost |
- |
- |
- |
- |
051 [1] 51 💬 |
160 |
Endoprost - 0.05 mg/0.5 ml concentrato per soluzione per infusione 1 fiala |
- |
- |
- |
- |
051 [1] 51 💬 |
161 |
Endoprost 0,05mg/0,5ml 1f |
- |
- |
- |
- |
051 [1] 51 💬 |
162 |
Endoprost 50*infus 1f 0,050mg/ |
- |
- |
- |
- |
051 [1] 51 💬 |
163 |
Endothelin receptor blocker |
- |
- |
- |
- |
051 [1] 51 💬 |
164 |
Erbitux |
- |
- |
- |
- |
051 [2] 51, 86 💬 |
165 |
Esbriet |
- |
- |
- |
- |
046 [4] 46, 51, 85, 228 💬 |
166 |
Ethanol |
Ethanol |
[4] D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542 💬 |
- |
- |
051 [4] 51, 97, 279, 280 💬 |
167 |
Ex vivo cultured human mesenchymal stem cells |
- |
- |
- |
- |
051 [1] 51 💬 |
168 |
Factor xiii |
Factor XIII (human) |
- |
- |
- |
051 [3] 51, 97, 288 💬 |
169 |
Fasudil |
Fasudil |
[1] D07941 D07941 💬 |
ROCK1 [2] ROCK1, ROCK2 💬 |
Axon guidance [22] Axon guidance, Chemokine signaling pathway, Focal adhesion, Human cytomegalovirus infection, Leukocyte transendothelial migration, MicroRNAs in cancer, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Proteoglycans in cancer, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, TGF-beta signaling pathway, Tight junction, Vascular smooth muscle contraction, Wnt signaling pathway, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway |
002 [2] 2 , 51 💬 |
170 |
Fibrogammin® 1250 |
- |
- |
- |
- |
051 [1] 51 💬 |
171 |
Fibrogammin®p, coagulation factor xiii concentrate (human) |
Factor XIII (human) |
- |
- |
- |
051 [1] 51 💬 |
172 |
Filgrastim |
Filgrastim |
[1] D03235 D03235 💬 |
CSF3R [1] CSF3R 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 [27] 2 , 6 , 13, 25, 26, 28, 34, 35, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬 |
173 |
Fludarabine |
Fludarabine |
[2] D01907 D01907, D07966 D07966 💬 |
RRM1 [1] RRM1 💬 |
Drug metabolism - other enzymes [5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
013 [17] 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 326 💬 |
174 |
Fludarabine phosphate |
Fludarabine |
[2] D01907 D01907, D07966 D07966 💬 |
RRM1 [1] RRM1 💬 |
Drug metabolism - other enzymes [5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
028 [11] 28, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285 💬 |
175 |
Fresolimumab |
Fresolimumab |
[1] D09620 D09620 💬 |
TGFB1 [3] TGFB1, TGFB2, TGFB3 💬 |
AGE-RAGE signaling pathway in diabetic complications [35] AGE-RAGE signaling pathway in diabetic complications, Amoebiasis, Cell cycle, Cellular senescence, Chagas disease, Chronic myeloid leukemia, Colorectal cancer, Cytokine-cytokine receptor interaction, Diabetic cardiomyopathy, Dilated cardiomyopathy, FoxO signaling pathway, Gastric cancer, Hepatitis B, Hepatocellular carcinoma, Hippo signaling pathway, Human T-cell leukemia virus 1 infection, Hypertrophic cardiomyopathy, Inflammatory bowel disease, Intestinal immune network for IgA production, Leishmaniasis, MAPK signaling pathway, Malaria, MicroRNAs in cancer, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, TGF-beta signaling pathway, Th17 cell differentiation, Toxoplasmosis, Tuberculosis |
051 [3] 51, 222, 274 💬 |
176 |
From august 2020 'no additional treatment' |
- |
- |
- |
- |
051 [1] 51 💬 |
177 |
Ft011 |
- |
- |
- |
- |
051 [1] 51 💬 |
178 |
G-csf |
Filgrastim |
[1] D03235 D03235 💬 |
CSF3R [1] CSF3R 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 [16] 2 , 6 , 11, 13, 16, 47, 49, 51, 60, 62, 65, 85, 96, 284, 285, 331 💬 |
179 |
G451990 |
- |
- |
- |
- |
051 [2] 51, 85 💬 |
180 |
Genetic: fcx-013 |
- |
- |
- |
- |
051 [1] 51 💬 |
181 |
Glivec |
- |
- |
- |
- |
051 [2] 51, 86 💬 |
182 |
Glivec 100 mg filmtabletten |
- |
- |
- |
- |
051 [2] 51, 86 💬 |
183 |
Glpg1690 |
- |
- |
- |
- |
051 [2] 51, 85 💬 |
184 |
Glycyrrhizin |
Glycyrrhizic acid |
[1] D00157 D00157 💬 |
- |
- |
051 [1] 51 💬 |
185 |
Gm-csf |
- |
- |
- |
- |
051 [3] 51, 60, 229 💬 |
186 |
Gran |
- |
- |
- |
- |
051 [1] 51 💬 |
187 |
Gs-248 |
- |
- |
- |
- |
051 [1] 51 💬 |
188 |
Gsk2330811 |
- |
- |
- |
- |
051 [2] 51, 96 💬 |
189 |
Gsk2330811 solution for injection, 100mg/ml |
- |
- |
- |
- |
051 [1] 51 💬 |
190 |
Hematopoietic stem cell transplantation |
- |
- |
- |
- |
011 [12] 11, 13, 14, 19, 20, 35, 46, 49, 51, 96, 234, 285 💬 |
191 |
Hidonac*ev 1fl 5g 25ml |
- |
- |
- |
- |
051 [1] 51 💬 |
192 |
High-dose intravenous immunoglobulin (venoglobulin-ih) |
- |
- |
- |
- |
051 [1] 51 💬 |
193 |
Hizentra |
- |
- |
- |
- |
014 [4] 14, 50, 51, 65 💬 |
194 |
Human anti-transforming growth factor beta-1 monoclonal antibody |
- |
- |
- |
- |
051 [1] 51 💬 |
195 |
Human normal immunoglobulin |
Human immunoglobulin G |
- |
- |
- |
011 [9] 11, 13, 14, 43, 45, 50, 51, 63, 65 💬 |
196 |
Human normal immunoglobulin for intravenous (iv) administration |
Human immunoglobulin G |
- |
- |
- |
051 [1] 51 💬 |
197 |
Human normal immunoglobulin for intravenous administration |
Human immunoglobulin G |
- |
- |
- |
014 [3] 14, 51, 65 💬 |
198 |
Human normal immunoglobulin for subcutaneous administration |
Human immunoglobulin G |
- |
- |
- |
051 [2] 51, 65 💬 |
199 |
Hyaluronidase |
Hyaluronidase |
[3] D04455 D04455, D04456 D04456, D06604 D06604 💬 |
- |
- |
028 [4] 28, 51, 65, 331 💬 |
200 |
Hyaluronidase injected intradermally |
Hyaluronidase |
[3] D04455 D04455, D04456 D04456, D06604 D06604 💬 |
- |
- |
051 [1] 51 💬 |
201 |
Hyperimmune caprine serum |
- |
- |
- |
- |
051 [1] 51 💬 |
202 |
Hyperoxia |
- |
- |
- |
- |
051 [2] 51, 85 💬 |
203 |
Ifetroban |
Ifetroban |
[1] D04500 D04500 💬 |
TBXA2R [1] TBXA2R 💬 |
Calcium signaling pathway [3] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Platelet activation |
051 [3] 51, 86, 113 💬 |
204 |
Igpro10 |
- |
- |
- |
- |
014 [3] 14, 51, 65 💬 |
205 |
Igpro20 |
- |
- |
- |
- |
014 [4] 14, 50, 51, 65 💬 |
206 |
Iguratimod |
Iguratimod |
[1] D01146 D01146 💬 |
NFKB1 [1] NFKB1 💬 |
AGE-RAGE signaling pathway in diabetic complications [72] AGE-RAGE signaling pathway in diabetic complications, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amoebiasis, Antifolate resistance, Apoptosis, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Chronic myeloid leukemia, Cocaine addiction, Coronavirus disease - COVID-19, Cytosolic DNA-sensing pathway, Diabetic cardiomyopathy, Epithelial cell signaling in Helicobacter pylori infection, Epstein-Barr virus infection, Fluid shear stress and atherosclerosis, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Longevity regulating pathway, MAPK signaling pathway, Measles, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prolactin signaling pathway, Prostate cancer, RIG-I-like receptor signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway |
046 [4] 46, 51, 53, 271 💬 |
207 |
Ilomedin |
- |
- |
- |
- |
051 [1] 51 💬 |
208 |
Iloprost |
Iloprost |
[1] D02721 D02721 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
051 [4] 51, 84, 85, 86 💬 |
209 |
Iloprost injection, for intravenous use |
Iloprost |
[1] D02721 D02721 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
051 [1] 51 💬 |
210 |
Iloprost low dose |
Iloprost |
[1] D02721 D02721 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
051 [1] 51 💬 |
211 |
Iloprost sale di trometamolo |
Iloprost |
[1] D02721 D02721 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
051 [1] 51 💬 |
212 |
Iloprost therapy up to 2 ng/kg x min |
Iloprost |
[1] D02721 D02721 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
051 [1] 51 💬 |
213 |
Iloprost trometamol |
Iloprost |
[2] D00396 D00396, D02721 D02721 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
051 [1] 51 💬 |
214 |
Imatinib |
Imatinib |
[2] D01441 D01441, D08066 D08066 💬 |
ABL1 [3] ABL1, KIT, PDGFRA 💬 |
Acute myeloid leukemia [31] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬 |
215 |
Imatinib mesilato |
Imatinib |
[2] D01441 D01441, D08066 D08066 💬 |
ABL1 [3] ABL1, KIT, PDGFRA 💬 |
Acute myeloid leukemia [31] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
051 [1] 51 💬 |
216 |
Imatinib mesylate |
Imatinib |
[2] D01441 D01441, D08066 D08066 💬 |
ABL1 [3] ABL1, KIT, PDGFRA 💬 |
Acute myeloid leukemia [31] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
013 [5] 13, 28, 34, 51, 86 💬 |
217 |
Imiquimod |
Imiquimod |
[1] D02500 D02500 💬 |
TLR7 [1] TLR7 💬 |
Coronavirus disease - COVID-19 [5] Coronavirus disease - COVID-19, Influenza A, Measles, Neutrophil extracellular trap formation, Toll-like receptor signaling pathway |
034 [2] 34, 51 💬 |
218 |
Imiquimod 5% cream |
Imiquimod |
[1] D02500 D02500 💬 |
TLR7 [1] TLR7 💬 |
Coronavirus disease - COVID-19 [5] Coronavirus disease - COVID-19, Influenza A, Measles, Neutrophil extracellular trap formation, Toll-like receptor signaling pathway |
034 [2] 34, 51 💬 |
219 |
Imnovid |
- |
- |
- |
- |
051 [1] 51 💬 |
220 |
Imnovid 1 mg hard capsules |
- |
- |
- |
- |
051 [1] 51 💬 |
221 |
Incb039110 |
- |
- |
- |
- |
051 [2] 51, 97 💬 |
222 |
Indocyanine green |
Indocyanine green |
[1] D01342 D01342 💬 |
- |
- |
046 [7] 46, 51, 96, 235, 278, 291, 296 💬 |
223 |
Indole |
Indole |
- |
- |
- |
051 [1] 51 💬 |
224 |
Influenza vaccine |
- |
- |
- |
- |
011 [5] 11, 13, 46, 51, 84 💬 |
225 |
Injection of allogeneic mesenchymal stem cells |
- |
- |
- |
- |
051 [1] 51 💬 |
226 |
Injection of autologous stromal vascular fraction |
- |
- |
- |
- |
051 [1] 51 💬 |
227 |
Interleukin 2 |
- |
- |
- |
- |
046 [9] 46, 49, 51, 56, 63, 95, 96, 97, 271 💬 |
228 |
Intravenous immunoglobulin |
- |
- |
- |
- |
013 [8] 13, 14, 35, 38, 39, 49, 51, 309 💬 |
229 |
Iontophoresis of treprostinil |
Treprostinil |
[1] D06213 D06213 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
051 [1] 51 💬 |
230 |
Itacitinib |
Itacitinib |
[1] D10944 D10944 💬 |
JAK1 [1] JAK1 💬 |
Coronavirus disease - COVID-19 [27] Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
046 [5] 46, 51, 60, 97, 228 💬 |
231 |
Iv cyclophosphamide |
Cyclophosphamide |
[2] D00287 D00287, D07760 D07760 💬 |
- |
- |
051 [1] 51 💬 |
232 |
Iva337 |
- |
- |
- |
- |
051 [1] 51 💬 |
233 |
Ivig |
Human immunoglobulin G |
- |
- |
- |
011 [8] 11, 13, 14, 17, 35, 50, 51, 65 💬 |
234 |
Jbt-101 |
- |
- |
- |
- |
049 [4] 49, 50, 51, 299 💬 |
235 |
Khk4827 |
- |
- |
- |
- |
037 [2] 37, 51 💬 |
236 |
Lactobacillus |
- |
- |
- |
- |
051 [1] 51 💬 |
237 |
Lanifibranor |
Lanifibranor |
- |
- |
- |
051 [1] 51 💬 |
238 |
Lenabasum |
- |
- |
- |
- |
050 [3] 50, 51, 299 💬 |
239 |
Lenabasum 20 mg |
- |
- |
- |
- |
050 [3] 50, 51, 299 💬 |
240 |
Lenabasum 20 mg powder in capsule |
- |
- |
- |
- |
051 [1] 51 💬 |
241 |
Lenabasum 5 mg |
- |
- |
- |
- |
050 [3] 50, 51, 299 💬 |
242 |
Lenabasum 5 mg powder in capsule |
- |
- |
- |
- |
051 [1] 51 💬 |
243 |
Leuprolide |
Leuprolide |
[2] D00989 D00989, D08113 D08113 💬 |
GNRHR [1] GNRHR 💬 |
GnRH signaling pathway [2] GnRH signaling pathway, Neuroactive ligand-receptor interaction |
001 [5] 1 , 2 , 3 , 51, 76 💬 |
244 |
Lidocaine |
Lidocaine |
[3] D00358 D00358, D02086 D02086, D08127 D08127 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
006 [10] 6 , 13, 34, 46, 51, 86, 168, 226, 231, 256 💬 |
245 |
Lidocaine 2% without vessel constrictor |
Lidocaine |
[3] D00358 D00358, D02086 D02086, D08127 D08127 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
051 [1] 51 💬 |
246 |
Lipitor |
- |
- |
- |
- |
051 [3] 51, 96, 299 💬 |
247 |
Liposomal bupivacaine |
Bupivacaine |
[2] D01450 D01450, D07552 D07552 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
051 [3] 51, 70, 96 💬 |
248 |
Mabp1 (bermekimab) |
Bermekimab |
[1] D11253 D11253 💬 |
IL1A [1] IL1A 💬 |
AGE-RAGE signaling pathway in diabetic complications [21] AGE-RAGE signaling pathway in diabetic complications, Alzheimer disease, Cellular senescence, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Inflammatory bowel disease, Influenza A, Leishmaniasis, MAPK signaling pathway, Measles, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Tuberculosis, Type I diabetes mellitus |
051 [1] 51 💬 |
249 |
Mabthera |
- |
- |
- |
- |
011 [22] 11, 13, 14, 19, 35, 43, 44, 46, 49, 50, 51, 52, 53, 61, 63, 64, 65, 83, 93, 162, 222, 271 💬 |
250 |
Macitentan |
Macitentan |
[1] D10135 D10135 💬 |
EDNRA [2] EDNRA, EDNRB 💬 |
Calcium signaling pathway [9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 [5] 51, 85, 86, 88, 210 💬 |
251 |
Macitentan 10 mg |
Macitentan |
[1] D10135 D10135 💬 |
EDNRA [2] EDNRA, EDNRB 💬 |
Calcium signaling pathway [9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 [3] 51, 86, 88 💬 |
252 |
Macitentan 10mg |
Macitentan |
[1] D10135 D10135 💬 |
EDNRA [2] EDNRA, EDNRB 💬 |
Calcium signaling pathway [9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 [1] 51 💬 |
253 |
Macitentan 3 mg |
Macitentan |
[1] D10135 D10135 💬 |
EDNRA [2] EDNRA, EDNRB 💬 |
Calcium signaling pathway [9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 [1] 51 💬 |
254 |
Macitentan 3mg |
Macitentan |
[1] D10135 D10135 💬 |
EDNRA [2] EDNRA, EDNRB 💬 |
Calcium signaling pathway [9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 [1] 51 💬 |
255 |
Medi-546 |
- |
- |
- |
- |
049 [2] 49, 51 💬 |
256 |
Medi-551 |
- |
- |
- |
- |
013 [2] 13, 51 💬 |
257 |
Medrone |
- |
- |
- |
- |
046 [4] 46, 51, 83, 162 💬 |
258 |
Mesenchymal stem cells |
- |
- |
- |
- |
002 [11] 2 , 6 , 13, 20, 49, 51, 60, 96, 222, 274, 299 💬 |
259 |
Mesenchymal stem cells from wharton ´s jellyintravenous infusion of mesenchymal stem cells from wharton ´s jelly |
- |
- |
- |
- |
051 [1] 51 💬 |
260 |
Mesenchymal stromal cells |
Human Umbilical Cord Mesenchymal Stem Cells |
- |
- |
- |
002 [9] 2 , 36, 49, 51, 60, 96, 97, 274, 284 💬 |
261 |
Mesna |
- |
- |
- |
- |
011 [11] 11, 13, 44, 45, 49, 51, 60, 65, 85, 96, 164 💬 |
262 |
Methotrexate |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
011 [35] 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬 |
263 |
Methylprednisolon |
Methylprednisolone |
[6] D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
013 [4] 13, 14, 51, 66 💬 |
264 |
Methylprednisolone |
Methylprednisolone |
[6] D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
002 [44] 2 , 6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬 |
265 |
Methylprednisolone acetate |
Acetate |
[6] D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
051 [1] 51 💬 |
266 |
Methylprednisolone sodium succinate |
Methylprednisolone |
[6] D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
013 [6] 13, 46, 49, 50, 51, 211 💬 |
267 |
Metoclopramide |
Metoclopramide |
[3] D00726 D00726, D02213 D02213, D05008 D05008 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
051 [1] 51 💬 |
268 |
Metoclopramide accord - 10 mg compresse 28 compresse in blister pvc/pvdc/al |
Metoclopramide |
[3] D00726 D00726, D02213 D02213, D05008 D05008 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
051 [1] 51 💬 |
269 |
Metronidazole |
Metronidazole |
[3] D00409 D00409, D05016 D05016, D05017 D05017 💬 |
- |
- |
046 [8] 46, 51, 63, 94, 95, 96, 97, 291 💬 |
270 |
Mg |
- |
- |
- |
- |
006 [3] 6 , 13, 51 💬 |
271 |
Mhsct |
- |
- |
- |
- |
051 [1] 51 💬 |
272 |
Microgynon |
- |
- |
- |
- |
013 [2] 13, 51 💬 |
273 |
Mizoribine |
Mizoribine |
[1] D01392 D01392 💬 |
IMPDH1 [2] IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
046 [8] 46, 49, 51, 53, 66, 94, 222, 224 💬 |
274 |
Mmf |
- |
- |
- |
- |
013 [13] 13, 35, 40, 49, 50, 51, 60, 65, 66, 222, 224, 226, 299 💬 |
275 |
Mpa |
- |
- |
- |
- |
049 [3] 49, 51, 60 💬 |
276 |
Mqx-503 |
- |
- |
- |
- |
051 [1] 51 💬 |
277 |
Msc |
- |
- |
- |
- |
006 [6] 6 , 51, 60, 96, 97, 271 💬 |
278 |
Mt-7117 |
- |
- |
- |
- |
051 [2] 51, 254 💬 |
279 |
Mycophenolate |
Mycophenolic acid |
[1] D05096 D05096 💬 |
IMPDH1 [2] IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
002 [34] 2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 💬 |
280 |
Mycophenolate mofetil |
Mycophenolate mofetil |
[4] D00752 D00752, D05094 D05094, D05095 D05095, D05096 D05096 💬 |
IMPDH1 [2] IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
002 [32] 2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬 |
281 |
Mycophenolate mofetil (mmf) |
Mycophenolate mofetil |
[4] D00752 D00752, D05094 D05094, D05095 D05095, D05096 D05096 💬 |
IMPDH1 [2] IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
013 [7] 13, 49, 51, 60, 65, 66, 222 💬 |
282 |
Mycophenolic acid |
Mycophenolic acid |
[1] D05096 D05096 💬 |
IMPDH1 [2] IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
011 [8] 11, 43, 49, 51, 60, 66, 96, 222 💬 |
283 |
N-acetylcysteine (nac) |
Acetylcysteine |
[1] D00221 D00221 💬 |
- |
- |
034 [3] 34, 51, 299 💬 |
284 |
Nac |
- |
- |
- |
- |
034 [5] 34, 51, 85, 90, 299 💬 |
285 |
Nd |
- |
- |
- |
- |
013 [4] 13, 46, 51, 97 💬 |
286 |
Neovasculgen |
- |
- |
- |
- |
051 [1] 51 💬 |
287 |
Neupogen |
- |
- |
- |
- |
013 [4] 13, 28, 51, 285 💬 |
288 |
Nilotinib |
Nilotinib |
[1] D08953 D08953 💬 |
ABL1 [4] ABL1, KIT, PDGFRA, PDGFRB 💬 |
Acute myeloid leukemia [32] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
006 [5] 6 , 8 , 34, 51, 86 💬 |
289 |
Nilotinib (tasigna) |
Nilotinib |
[1] D08953 D08953 💬 |
ABL1 [4] ABL1, KIT, PDGFRA, PDGFRB 💬 |
Acute myeloid leukemia [32] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
051 [1] 51 💬 |
290 |
Nintedanib |
Nintedanib |
[1] D10481 D10481 💬 |
FGFR1 [8] FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬 |
Adherens junction [34] Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway |
051 [5] 51, 85, 89, 227, 228 💬 |
291 |
Nitroglycerin |
Nitroglycerin |
[1] D00515 D00515 💬 |
- |
- |
051 [1] 51 💬 |
292 |
Nitroglycerin ointment 2% |
Nitroglycerin |
[1] D00515 D00515 💬 |
- |
- |
051 [1] 51 💬 |
293 |
Nitroglycerine |
Nitroglycerin |
[1] D00515 D00515 💬 |
- |
- |
046 [2] 46, 51 💬 |
294 |
Nitroglycerine gel |
Nitroglycerin |
[1] D00515 D00515 💬 |
- |
- |
051 [1] 51 💬 |
295 |
Nitroprusside |
Nitroprusside |
[1] D00614 D00614 💬 |
- |
- |
051 [1] 51 💬 |
296 |
Nivolumab |
Nivolumab |
[1] D10316 D10316 💬 |
PDCD1 [1] PDCD1 💬 |
Cell adhesion molecules [3] Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway |
013 [12] 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159 💬 |
297 |
Non applicabile |
- |
- |
- |
- |
051 [1] 51 💬 |
298 |
Non propietry, therefore n/a |
- |
- |
- |
- |
051 [1] 51 💬 |
299 |
Null |
- |
- |
- |
- |
006 [16] 6 , 13, 15, 28, 37, 46, 49, 51, 63, 86, 90, 96, 97, 107, 145, 271 💬 |
300 |
Ofev |
- |
- |
- |
- |
051 [5] 51, 85, 89, 227, 228 💬 |
301 |
Omeprazole |
Omeprazole |
[4] D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
006 [16] 6 , 8 , 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬 |
302 |
Omeprazole 20mg |
Omeprazole |
[4] D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
051 [1] 51 💬 |
303 |
Onabotulinumtoxin a |
- |
- |
- |
- |
051 [2] 51, 226 💬 |
304 |
Ophthalmic emulsion |
- |
- |
- |
- |
051 [2] 51, 53 💬 |
305 |
Opsumit 10 mg tablet |
- |
- |
- |
- |
051 [1] 51 💬 |
306 |
Oral bovine type i collagen |
Bovine type I collagen |
- |
- |
- |
051 [1] 51 💬 |
307 |
Oral ifetroban |
Ifetroban |
[1] D04500 D04500 💬 |
TBXA2R [1] TBXA2R 💬 |
Calcium signaling pathway [3] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Platelet activation |
051 [2] 51, 86 💬 |
308 |
Oral treprostinil |
Treprostinil |
[1] D06213 D06213 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
051 [2] 51, 86 💬 |
309 |
Orencia |
- |
- |
- |
- |
044 [13] 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 160, 222, 271 💬 |
310 |
Orm-12471 |
- |
- |
- |
- |
051 [1] 51 💬 |
311 |
Orm-12471 30mg |
- |
- |
- |
- |
051 [1] 51 💬 |
312 |
Orm-12741 |
ORM-12741 |
- |
- |
- |
051 [1] 51 💬 |
313 |
Other vasodilator |
- |
- |
- |
- |
051 [1] 51 💬 |
314 |
Other: biopsy |
- |
- |
- |
- |
051 [1] 51 💬 |
315 |
Other: bronchoalveolar samples |
- |
- |
- |
- |
051 [1] 51 💬 |
316 |
Other: flow cytometry |
- |
- |
- |
- |
028 [3] 28, 51, 60 💬 |
317 |
Other: laboratory biomarker analysis |
- |
- |
- |
- |
011 [21] 11, 13, 14, 16, 26, 28, 34, 49, 51, 60, 62, 65, 89, 96, 97, 232, 283, 284, 285, 298, 331 💬 |
318 |
Other: physalis angulata ethanol extract |
Ethanol |
[4] D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542 💬 |
- |
- |
051 [1] 51 💬 |
319 |
Other: quality-of-life assessment |
- |
- |
- |
- |
034 [5] 34, 36, 51, 96, 298 💬 |
320 |
Other: questionnaire administration |
- |
- |
- |
- |
016 [4] 16, 34, 51, 298 💬 |
321 |
Other: rosemary essential oil |
Rosemary |
- |
- |
- |
051 [1] 51 💬 |
322 |
Other: sodium chloride |
Chloride ion |
[1] D02056 D02056 💬 |
- |
- |
051 [1] 51 💬 |
323 |
Other: vasculopathy assessment |
- |
- |
- |
- |
051 [1] 51 💬 |
324 |
Ozone |
Ozone |
- |
- |
- |
049 [2] 49, 51 💬 |
325 |
P144 |
- |
- |
- |
- |
051 [1] 51 💬 |
326 |
P144 cream |
- |
- |
- |
- |
051 [1] 51 💬 |
327 |
P144 cytokine inhibitor |
- |
- |
- |
- |
051 [1] 51 💬 |
328 |
P144 cytokines inhibitors |
- |
- |
- |
- |
051 [1] 51 💬 |
329 |
P144 digna cream |
- |
- |
- |
- |
051 [1] 51 💬 |
330 |
P144. cytokines inhibitors |
- |
- |
- |
- |
051 [1] 51 💬 |
331 |
Paquinimod |
Paquinimod |
- |
- |
- |
049 [2] 49, 51 💬 |
332 |
Part b open-label extension |
- |
- |
- |
- |
051 [1] 51 💬 |
333 |
Patients will be randomized to receive ehp-101 |
- |
- |
- |
- |
051 [1] 51 💬 |
334 |
Penicillamine |
Penicillamine |
[1] D00496 D00496 💬 |
- |
- |
051 [2] 51, 171 💬 |
335 |
Peripheral blood stem cells |
- |
- |
- |
- |
051 [2] 51, 65 💬 |
336 |
Pfd |
- |
- |
- |
- |
051 [2] 51, 298 💬 |
337 |
Phosphate |
Phosphate ion |
- |
- |
- |
002 [30] 2 , 3 , 11, 12, 13, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 256, 276, 283, 284, 285, 286, 299 💬 |
338 |
Phosphodiesterase inhibitors |
- |
- |
- |
- |
051 [1] 51 💬 |
339 |
Physiological saline |
- |
- |
- |
- |
051 [1] 51 💬 |
340 |
Pirfenidone |
Pirfenidone |
[1] D01583 D01583 💬 |
CCL2 [6] CCL2, IL10, IL1A, IL1B, IL6, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [82] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
034 [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬 |
341 |
Pirfenidone (pfd) |
Pirfenidone |
[1] D01583 D01583 💬 |
CCL2 [6] CCL2, IL10, IL1A, IL1B, IL6, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [82] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
051 [1] 51 💬 |
342 |
Placebo |
- |
- |
- |
- |
003 [26] 3 , 5 , 6 , 13, 14, 37, 40, 46, 49, 50, 51, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276 💬 |
343 |
Platelet gel |
- |
- |
- |
- |
051 [1] 51 💬 |
344 |
Plerixafor |
Plerixafor |
[1] D08971 D08971 💬 |
CXCR4 [1] CXCR4 💬 |
Axon guidance [12] Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral protein interaction with cytokine and cytokine receptor |
020 [5] 20, 51, 65, 285, 299 💬 |
345 |
Pletal |
- |
- |
- |
- |
051 [1] 51 💬 |
346 |
Polydeoxyribonucleotides |
- |
- |
- |
- |
051 [2] 51, 70 💬 |
347 |
Pomalidomida |
Pomalidomide |
[1] D08976 D08976 💬 |
IL6 [2] IL6, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [78] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
051 [1] 51 💬 |
348 |
Pomalidomide |
Pomalidomide |
[1] D08976 D08976 💬 |
IL6 [2] IL6, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [78] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
028 [6] 28, 34, 51, 85, 227, 331 💬 |
349 |
Pomalidomide (cc-4047) |
Pomalidomide |
[1] D08976 D08976 💬 |
IL6 [2] IL6, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [78] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
051 [1] 51 💬 |
350 |
Pr1 |
- |
- |
- |
- |
051 [1] 51 💬 |
351 |
Prednisolon |
- |
- |
- |
- |
046 [6] 46, 50, 51, 66, 96, 97 💬 |
352 |
Prednisolona |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
051 [1] 51 💬 |
353 |
Prednisolone |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
011 [40] 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬 |
354 |
Prednisolone 5 mg |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [2] 46, 51 💬 |
355 |
Prednisolone 5mg gastro-resistant tablets |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
051 [1] 51 💬 |
356 |
Prednisolone and taper |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
051 [1] 51 💬 |
357 |
Prednisoloni |
- |
- |
- |
- |
051 [1] 51 💬 |
358 |
Prednisolonum |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
051 [1] 51 💬 |
359 |
Prednisone |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
002 [47] 2 , 6 , 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 93, 95, 96, 97, 113, 127, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 💬 |
360 |
Prednizolon |
- |
- |
- |
- |
051 [1] 51 💬 |
361 |
Prednizolonas |
- |
- |
- |
- |
051 [1] 51 💬 |
362 |
Privigen |
- |
- |
- |
- |
011 [4] 11, 14, 51, 65 💬 |
363 |
Procedure: 2 ml of whole blood sample will be collected on edta tube |
Edetic acid |
[8] D00052 D00052, D00571 D00571, D01802 D01802, D03943 D03943, D03944 D03944, D03945 D03945, D03946 D03946, D03947 D03947 💬 |
- |
- |
051 [1] 51 💬 |
364 |
Procedure: adipose tissue harvest |
- |
- |
- |
- |
051 [1] 51 💬 |
365 |
Procedure: allogeneic hematopoietic stem cell transplantation |
- |
- |
- |
- |
028 [8] 28, 51, 60, 62, 65, 164, 284, 285 💬 |
366 |
Procedure: autologous hematopoietic stem cell transplantation |
- |
- |
- |
- |
011 [6] 11, 13, 14, 28, 49, 51 💬 |
367 |
Procedure: biopsy |
- |
- |
- |
- |
051 [3] 51, 78, 193 💬 |
368 |
Procedure: bone marrow transplantation |
- |
- |
- |
- |
051 [4] 51, 60, 284, 285 💬 |
369 |
Procedure: leukapheresis |
- |
- |
- |
- |
049 [5] 49, 51, 96, 284, 285 💬 |
370 |
Procedure: leukopheresis |
- |
- |
- |
- |
051 [1] 51 💬 |
371 |
Procedure: nonmyeloablative allogeneic hematopoietic stem cell transplantation |
- |
- |
- |
- |
028 [6] 28, 51, 60, 62, 65, 285 💬 |
372 |
Procedure: order of two elements of surgical procedure |
- |
- |
- |
- |
051 [1] 51 💬 |
373 |
Procedure: peripheral blood stem cell transplantation |
- |
- |
- |
- |
011 [11] 11, 13, 14, 28, 51, 60, 62, 65, 283, 284, 285 💬 |
374 |
Procedure: quality-of-life assessment |
- |
- |
- |
- |
028 [3] 28, 34, 51 💬 |
375 |
Procedure: reduced intensity allogeneic hematopoietic stem cell transplantation |
- |
- |
- |
- |
051 [1] 51 💬 |
376 |
Procedure: reduced intensity allogeneic transplant |
- |
- |
- |
- |
049 [2] 49, 51 💬 |
377 |
Procedure: self bone marrow transplant |
- |
- |
- |
- |
051 [1] 51 💬 |
378 |
Procedure: stem cell transplantation |
- |
- |
- |
- |
019 [6] 19, 51, 60, 62, 65, 326 💬 |
379 |
Procedure: total body irradiation |
- |
- |
- |
- |
019 [6] 19, 20, 51, 60, 65, 285 💬 |
380 |
Procedure: total-body irradiation |
- |
- |
- |
- |
051 [1] 51 💬 |
381 |
Propylene glycol |
Propylene glycol |
[1] D00078 D00078 💬 |
- |
- |
028 [2] 28, 51 💬 |
382 |
Prostanoids |
- |
- |
- |
- |
051 [1] 51 💬 |
383 |
Prucalopride |
Prucalopride |
[1] D09205 D09205 💬 |
HTR4 [1] HTR4 💬 |
Calcium signaling pathway [4] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse, cAMP signaling pathway |
013 [3] 13, 51, 96 💬 |
384 |
Prucalopride succinate |
Prucalopride |
[1] D09205 D09205 💬 |
HTR4 [1] HTR4 💬 |
Calcium signaling pathway [4] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse, cAMP signaling pathway |
051 [1] 51 💬 |
385 |
Qax576 |
- |
- |
- |
- |
051 [4] 51, 85, 96, 98 💬 |
386 |
Rabbit |
Rabbit |
- |
- |
- |
011 [8] 11, 13, 49, 51, 60, 65, 96, 285 💬 |
387 |
Rabeprazole |
Rabeprazole |
[2] D00724 D00724, D08463 D08463 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
002 [2] 2 , 51 💬 |
388 |
Radiation: cone beam computed tomography (cbct) |
Tricyclazole |
- |
- |
- |
051 [1] 51 💬 |
389 |
Radiation: intensity-modulated radiation therapy |
- |
- |
- |
- |
051 [1] 51 💬 |
390 |
Radiation: total body irradiation |
- |
- |
- |
- |
036 [7] 36, 49, 51, 60, 65, 283, 284 💬 |
391 |
Radiation: total-body irradiation |
- |
- |
- |
- |
028 [9] 28, 51, 60, 62, 65, 96, 283, 284, 285 💬 |
392 |
Rapamycin |
Sirolimus |
[1] D00753 D00753 💬 |
MTOR [1] MTOR 💬 |
AMPK signaling pathway [50] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
002 [18] 2 , 15, 34, 35, 46, 49, 51, 60, 61, 67, 86, 89, 96, 157, 158, 256, 278, 279 💬 |
393 |
Ratg |
Antithymocyte immunoglobulin (rabbit) |
- |
- |
- |
013 [3] 13, 51, 60 💬 |
394 |
Rbatg |
- |
- |
- |
- |
051 [2] 51, 96 💬 |
395 |
Recombinant humanized anti-human monoclonal antibody directed against the il-6r |
- |
- |
- |
- |
046 [2] 46, 51 💬 |
396 |
Relaxin |
- |
- |
- |
- |
051 [1] 51 💬 |
397 |
Resolor |
- |
- |
- |
- |
051 [1] 51 💬 |
398 |
Resolor*28cpr riv 2mg |
- |
- |
- |
- |
051 [1] 51 💬 |
399 |
Resunab, ajulemic acid, anabasum |
Ajulemic acid |
[1] D11312 D11312 💬 |
CNR2 [1] CNR2 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
050 [3] 50, 51, 299 💬 |
400 |
Rilonacept |
Rilonacept |
[1] D06635 D06635 💬 |
IL1A [2] IL1A, IL1B 💬 |
AGE-RAGE signaling pathway in diabetic complications [43] AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection |
051 [4] 51, 106, 107, 266 💬 |
401 |
Ringer lactate |
- |
- |
- |
- |
051 [1] 51 💬 |
402 |
Riocigu |
- |
- |
- |
- |
051 [1] 51 💬 |
403 |
Riociguat |
Riociguat |
[1] D09572 D09572 💬 |
GUCY1A1 [3] GUCY1A1, GUCY1A2, GUCY1B1 💬 |
Circadian entrainment [11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
051 [6] 51, 84, 86, 88, 225, 299 💬 |
404 |
Riociguat (adempas, bay63-2521) |
Riociguat |
[1] D09572 D09572 💬 |
GUCY1A1 [3] GUCY1A1, GUCY1A2, GUCY1B1 💬 |
Circadian entrainment [11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
051 [4] 51, 86, 88, 299 💬 |
405 |
Riociguat coated tablet 0.5 mg |
Riociguat |
[1] D09572 D09572 💬 |
GUCY1A1 [3] GUCY1A1, GUCY1A2, GUCY1B1 💬 |
Circadian entrainment [11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
051 [1] 51 💬 |
406 |
Riociguat coated tablet 1.0 mg |
Riociguat |
[1] D09572 D09572 💬 |
GUCY1A1 [3] GUCY1A1, GUCY1A2, GUCY1B1 💬 |
Circadian entrainment [11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
051 [1] 51 💬 |
407 |
Riociguat coated tablet 1.5 mg |
Riociguat |
[1] D09572 D09572 💬 |
GUCY1A1 [3] GUCY1A1, GUCY1A2, GUCY1B1 💬 |
Circadian entrainment [11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
051 [1] 51 💬 |
408 |
Riociguat coated tablet 2.0 mg |
Riociguat |
[1] D09572 D09572 💬 |
GUCY1A1 [3] GUCY1A1, GUCY1A2, GUCY1B1 💬 |
Circadian entrainment [11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
051 [1] 51 💬 |
409 |
Riociguat coated tablet 2.5 m |
Riociguat |
[1] D09572 D09572 💬 |
GUCY1A1 [3] GUCY1A1, GUCY1A2, GUCY1B1 💬 |
Circadian entrainment [11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
051 [1] 51 💬 |
410 |
Riociguat coated tablet 2.5 mg |
Riociguat |
[1] D09572 D09572 💬 |
GUCY1A1 [3] GUCY1A1, GUCY1A2, GUCY1B1 💬 |
Circadian entrainment [11] Circadian entrainment, Gap junction, Long-term depression, Metabolic pathways, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
051 [1] 51 💬 |
411 |
Rituximab |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
011 [47] 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬 |
412 |
Ro 47-0203 |
- |
- |
- |
- |
051 [4] 51, 85, 86, 88 💬 |
413 |
Ro 487-7533/f10-04 |
- |
- |
- |
- |
041 [4] 41, 46, 51, 107 💬 |
414 |
Ro47-0203 / act-050088 |
- |
- |
- |
- |
051 [2] 51, 86 💬 |
415 |
Ro487-7533/f10-04 |
- |
- |
- |
- |
046 [2] 46, 51 💬 |
416 |
Roactemra |
- |
- |
- |
- |
040 [9] 40, 41, 46, 51, 86, 107, 266, 271, 331 💬 |
417 |
Roactemra 162 mg |
- |
- |
- |
- |
046 [2] 46, 51 💬 |
418 |
Rosemary |
Rosemary |
- |
- |
- |
051 [1] 51 💬 |
419 |
Rosuvastatin |
Rosuvastatin |
[2] D01915 D01915, D08492 D08492 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
006 [11] 6 , 18, 46, 49, 51, 56, 79, 96, 97, 271, 299 💬 |
420 |
Saccharomyces |
- |
- |
- |
- |
051 [1] 51 💬 |
421 |
Saccharomyces boulardii oral tablet |
- |
- |
- |
- |
051 [1] 51 💬 |
422 |
Sar100842 |
- |
- |
- |
- |
051 [1] 51 💬 |
423 |
Sar156597 |
- |
- |
- |
- |
051 [2] 51, 85 💬 |
424 |
Sar156597 (act14604) |
- |
- |
- |
- |
051 [1] 51 💬 |
425 |
Sar231893 |
- |
- |
- |
- |
051 [2] 51, 160 💬 |
426 |
Selexipag |
Selexipag |
[1] D09994 D09994 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
051 [5] 51, 70, 84, 86, 88 💬 |
427 |
Sildenafil |
Sildenafil |
[2] D02229 D02229, D08514 D08514 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
006 [17] 6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬 |
428 |
Sildenafil 20mg |
Sildenafil |
[2] D02229 D02229, D08514 D08514 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
051 [2] 51, 86 💬 |
429 |
Sildenafil 20mg and bosentan 62.5mg |
Bosentan |
[4] D01227 D01227, D02229 D02229, D07538 D07538, D08514 D08514 💬 |
EDNRA [3] EDNRA, EDNRB, PDE5A 💬 |
Calcium signaling pathway [11] Calcium signaling pathway, Melanogenesis, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 [2] 51, 86 💬 |
430 |
Sildenafil citrate |
Sildenafil |
[2] D02229 D02229, D08514 D08514 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
051 [4] 51, 85, 86, 225 💬 |
431 |
Sildenafil therapy |
Sildenafil |
[2] D02229 D02229, D08514 D08514 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
051 [1] 51 💬 |
432 |
Simvastatin |
Simvastatin |
[1] D00434 D00434 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
006 [21] 6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬 |
433 |
Sinvacor |
- |
- |
- |
- |
051 [1] 51 💬 |
434 |
Sinvacor*28cpr riv 20mg |
- |
- |
- |
- |
051 [1] 51 💬 |
435 |
Sirolimus |
Sirolimus |
[1] D00753 D00753 💬 |
MTOR [1] MTOR 💬 |
AMPK signaling pathway [50] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
006 [35] 6 , 13, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 89, 98, 127, 137, 157, 158, 192, 222, 277, 278, 279, 280, 281, 283, 285, 331 💬 |
436 |
Sodium chloride |
Chloride ion |
[1] D02056 D02056 💬 |
- |
- |
006 [20] 6 , 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 78, 96, 168, 193, 227, 228, 271, 288, 299 💬 |
437 |
Sodium fluoride |
Sodium fluoride |
[1] D00943 D00943 💬 |
- |
- |
051 [1] 51 💬 |
438 |
Sodium fluoride 18f |
Sodium fluoride |
[1] D00943 D00943 💬 |
- |
- |
051 [1] 51 💬 |
439 |
Sodium nitroprusside |
Nitroprusside |
[1] D00614 D00614 💬 |
- |
- |
051 [1] 51 💬 |
440 |
Sodium thiosulfate |
- |
- |
- |
- |
050 [2] 50, 51 💬 |
441 |
Sodium thiosulfate 10% |
- |
- |
- |
- |
050 [2] 50, 51 💬 |
442 |
Sodium thiosulfate pentahydrate |
- |
- |
- |
- |
050 [2] 50, 51 💬 |
443 |
Solu-medrol |
- |
- |
- |
- |
013 [7] 13, 49, 50, 51, 53, 97, 211 💬 |
444 |
Solu-medrone |
- |
- |
- |
- |
051 [3] 51, 83, 162 💬 |
445 |
Soluble ve cadherin |
- |
- |
- |
- |
051 [1] 51 💬 |
446 |
Standard of care |
- |
- |
- |
- |
006 [12] 6 , 13, 14, 46, 49, 51, 63, 64, 79, 85, 158, 271 💬 |
447 |
Sterile saline solution |
- |
- |
- |
- |
051 [1] 51 💬 |
448 |
Steroids |
- |
- |
- |
- |
046 [7] 46, 50, 51, 63, 66, 96, 97 💬 |
449 |
Sti571 |
- |
- |
- |
- |
051 [2] 51, 86 💬 |
450 |
Stromal vascular fraction |
- |
- |
- |
- |
051 [1] 51 💬 |
451 |
Sts |
- |
- |
- |
- |
050 [2] 50, 51 💬 |
452 |
Study of the gene expression profile |
- |
- |
- |
- |
051 [1] 51 💬 |
453 |
Tacrolimus |
Tacrolimus |
[2] D00107 D00107, D08556 D08556 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
002 [32] 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬 |
454 |
Tadalafil |
Tadalafil |
[1] D02008 D02008 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
006 [7] 6 , 51, 75, 84, 86, 113, 210 💬 |
455 |
Tadalafil and ambrisentan upfront combination therapy |
Ambrisentan |
[2] D02008 D02008, D07077 D07077 💬 |
EDNRA [2] EDNRA, PDE5A 💬 |
Calcium signaling pathway [9] Calcium signaling pathway, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 [2] 51, 86 💬 |
456 |
Tepezza |
- |
- |
- |
- |
051 [1] 51 💬 |
457 |
Terguride |
Terguride |
[1] D01348 D01348 💬 |
DRD2 [2] DRD2, PRL 💬 |
Alcoholism [12] Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway |
051 [2] 51, 86 💬 |
458 |
Terguride hydrogenmaleate |
Terguride |
[1] D01348 D01348 💬 |
DRD2 [2] DRD2, PRL 💬 |
Alcoholism [12] Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway |
051 [1] 51 💬 |
459 |
Thalidomide |
Thalidomide |
[1] D00754 D00754 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
002 [20] 2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 300, 331 💬 |
460 |
Thiotepa |
Thiotepa |
[1] D00583 D00583 💬 |
- |
- |
013 [11] 13, 19, 20, 28, 51, 60, 65, 85, 96, 164, 284 💬 |
461 |
Thymoglobulin |
Antithymocyte immunoglobulin (rabbit) |
- |
- |
- |
036 [6] 36, 51, 60, 65, 96, 326 💬 |
462 |
Thymoglobuline |
Antithymocyte immunoglobulin (rabbit) |
- |
- |
- |
013 [5] 13, 36, 51, 60, 96 💬 |
463 |
Tocilizumab |
Tocilizumab |
[1] D02596 D02596 💬 |
IL6R [1] IL6R 💬 |
Coronavirus disease - COVID-19 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
002 [18] 2 , 13, 40, 41, 42, 43, 46, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬 |
464 |
Tocilizumab [roactemra/actemra] |
Tocilizumab |
[1] D02596 D02596 💬 |
IL6R [1] IL6R 💬 |
Coronavirus disease - COVID-19 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
046 [4] 46, 51, 107, 331 💬 |
465 |
Tocilizumab sc 162 mg/0.9 ml prefilled syringe with safety device (pfs) |
Tocilizumab |
[1] D02596 D02596 💬 |
IL6R [1] IL6R 💬 |
Coronavirus disease - COVID-19 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
051 [1] 51 💬 |
466 |
Tofacitinib |
Tofacitinib |
[1] D09970 D09970 💬 |
JAK1 [4] JAK1, JAK2, JAK3, TYK2 💬 |
AGE-RAGE signaling pathway in diabetic complications [35] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
011 [12] 11, 40, 46, 49, 50, 51, 53, 84, 96, 97, 107, 271 💬 |
467 |
Topical amphimatrix |
- |
- |
- |
- |
051 [1] 51 💬 |
468 |
Topical amphimatrix with nitroglycerin (mqx-503) |
Nitroglycerin |
[1] D00515 D00515 💬 |
- |
- |
051 [1] 51 💬 |
469 |
Topical calcipotriene 0.005% ointment |
Calcipotriol |
[1] D01125 D01125 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
051 [1] 51 💬 |
470 |
Topical organogel with nitroglycerin |
Nitroglycerin |
[1] D00515 D00515 💬 |
- |
- |
051 [1] 51 💬 |
471 |
Tracleer |
- |
- |
- |
- |
013 [8] 13, 51, 84, 85, 86, 88, 210, 211 💬 |
472 |
Tracleer*125mg 56cpr riv. |
- |
- |
- |
- |
051 [2] 51, 86 💬 |
473 |
Tracleer*56cpr riv 125mg |
- |
- |
- |
- |
051 [3] 51, 86, 88 💬 |
474 |
Transdihydrolisuride |
- |
- |
- |
- |
051 [2] 51, 86 💬 |
475 |
Treprostinil |
Treprostinil |
[1] D06213 D06213 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
051 [6] 51, 84, 85, 86, 88, 210 💬 |
476 |
Treprostinil diethanolamine |
Treprostinil |
[1] D06213 D06213 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
051 [2] 51, 86 💬 |
477 |
Treprostinil sodium |
Treprostinil |
[1] D06213 D06213 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
051 [3] 51, 86, 88 💬 |
478 |
Trimebutine |
Trimebutine |
[1] D08639 D08639 💬 |
OPRK1 [2] OPRK1, OPRM1 💬 |
Estrogen signaling pathway [3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
051 [1] 51 💬 |
479 |
Trometamol |
Tromethamine |
[1] D00396 D00396 💬 |
- |
- |
051 [1] 51 💬 |
480 |
Ucmsc |
- |
- |
- |
- |
051 [2] 51, 94 💬 |
481 |
Urine sample |
- |
- |
- |
- |
049 [3] 49, 51, 61 💬 |
482 |
Ut-15 sr |
- |
- |
- |
- |
051 [1] 51 💬 |
483 |
Ut-15c sr |
- |
- |
- |
- |
051 [2] 51, 86 💬 |
484 |
Ut-15c-sr |
- |
- |
- |
- |
051 [2] 51, 86 💬 |
485 |
Vaseline |
- |
- |
- |
- |
051 [1] 51 💬 |
486 |
Veledimex |
Veledimex |
[1] D10678 D10678 💬 |
- |
- |
051 [1] 51 💬 |
487 |
Vessel |
- |
- |
- |
- |
013 [4] 13, 51, 271, 288 💬 |
488 |
Vib7734 |
- |
- |
- |
- |
049 [4] 49, 50, 51, 53 💬 |
489 |
Vip |
- |
- |
- |
- |
049 [3] 49, 51, 86 💬 |
490 |
Vivomixx probiotics |
- |
- |
- |
- |
051 [1] 51 💬 |
491 |
Volibris |
- |
- |
- |
- |
051 [4] 51, 85, 86, 88 💬 |
492 |
Water |
Water |
[1] D00001 D00001 💬 |
- |
- |
002 [22] 2 , 5 , 6 , 13, 17, 19, 35, 46, 51, 53, 56, 57, 63, 65, 67, 78, 84, 96, 97, 226, 278, 299 💬 |
493 |
Yellow fever vaccine |
Yellow Fever Vaccine |
[1] D06347 D06347 💬 |
- |
- |
040 [7] 40, 44, 46, 50, 51, 52, 53 💬 |
494 |
Yellow fever vaccine (17d) |
Yellow Fever Vaccine |
[1] D06347 D06347 💬 |
- |
- |
040 [7] 40, 44, 46, 50, 51, 52, 53 💬 |
495 |
Zd4054 |
- |
- |
- |
- |
051 [1] 51 💬 |
496 |
Zibotentan |
Zibotentan |
[1] D07741 D07741 💬 |
EDNRA [1] EDNRA 💬 |
Calcium signaling pathway [7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 [1] 51 💬 |
497 |
Ziritaxestat |
Ziritaxestat |
[1] D11844 D11844 💬 |
ENPP2 [1] ENPP2 💬 |
Ether lipid metabolism [1] Ether lipid metabolism |
051 [2] 51, 85 💬 |